- Home
- CELC vs RSVR Comparison
CELC vs RSVR Comparison
Compare CELC & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- RSVR
- Stock Information
- Founded
- CELC 2011
- RSVR 2007
- Country
- CELC United States
- RSVR United States
- Employees
- CELC N/A
- RSVR N/A
- Industry
- CELC Medical Specialities
- RSVR Movies/Entertainment
- Sector
- CELC Health Care
- RSVR Consumer Discretionary
- Exchange
- CELC Nasdaq
- RSVR Nasdaq
- Market Cap
- CELC 440.0M
- RSVR 504.1M
- IPO Year
- CELC 2017
- RSVR N/A
- Fundamental
- Price
- CELC $51.79
- RSVR $7.67
- Analyst Decision
- CELC Strong Buy
- RSVR Strong Buy
- Analyst Count
- CELC 6
- RSVR 1
- Target Price
- CELC $46.50
- RSVR $11.50
- AVG Volume (30 Days)
- CELC 2.9M
- RSVR 72.6K
- Earning Date
- CELC 08-14-2025
- RSVR 08-05-2025
- Dividend Yield
- CELC N/A
- RSVR N/A
- EPS Growth
- CELC N/A
- RSVR N/A
- EPS
- CELC N/A
- RSVR 0.12
- Revenue
- CELC N/A
- RSVR $161,553,186.00
- Revenue This Year
- CELC N/A
- RSVR $7.04
- Revenue Next Year
- CELC N/A
- RSVR $6.23
- P/E Ratio
- CELC N/A
- RSVR $65.95
- Revenue Growth
- CELC N/A
- RSVR 9.65
- 52 Week Low
- CELC $7.58
- RSVR $6.56
- 52 Week High
- CELC $53.70
- RSVR $9.83
- Technical
- Relative Strength Index (RSI)
- CELC 92.18
- RSVR 48.47
- Support Level
- CELC $38.00
- RSVR $7.54
- Resistance Level
- CELC $53.40
- RSVR $7.86
- Average True Range (ATR)
- CELC 3.33
- RSVR 0.27
- MACD
- CELC 0.92
- RSVR -0.02
- Stochastic Oscillator
- CELC 89.44
- RSVR 28.32
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. It operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the Music Publishing segment.